Lipoatrophy common in children receiving d4T in South Africa
Lopinavir/ritonavir cuts malaria risk in children with HIV
Once-a-month HIV drug maintains good levels for prevention; few side-effects so far
Four doses of PrEP a week may be enough to protect
A tale of two trials: how adherence is everything in PrEP